Global Vaccine Alliance, Bharat Biotech In Talks Over Covaxin Use: Report
NDTV
The Gavi vaccine alliance said it was also working with the Serum Institute of India for the supply of Novavax vaccine to COVAX.
The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told news agency Reuters on Thursday.
"We are in discussion with (Bharat Biotech) as we consider the overall needs of the COVAX portfolio in 2022. However, we have no agreement for supply of Covaxin to COVAX at this time," the spokesperson said in an email.
The World Health Organization in November gave Covaxin, India's first homegrown COVID-19 vaccine, approval for emergency use. Three of the 10 vaccines the global agency has approved are mass-produced in India.
About 180 million Covaxin doses have been administered in India and more than 3 million doses have been exported or donated.
